Bosutinib (SKI-606)

Name: Bosutinib (SKI-606)
Brand: Selleck Chemicals
SKU: S1014
Rating: 5 (92 reviews)

For research use only.

Licensed by Pfizer Catalog No.S1014

92 publications

CAS No. 380843-75-4

Bosutinib (SKI-606) is a novel, dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM in cell-free assays, respectively. Bosutinib also effectively decreases the activity of PI3K/AKT/mTOR, MAPK/ERK and JAK/STAT3 signaling pathways by blocking the phosphorylation levels of p-ERK, p-S6, and p-STAT3. Bosutinib promotes autophagy.

Selleck's Bosutinib (SKI-606) has been cited by 92 publications

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Nat Med, 2018, 24(2):232-238

PubMed: 29309057 ( click the link to review the publication )

Cancer Discov, 2016, 6(7):727-39

PubMed: 27231123 ( click the link to review the publication )

Drug Metab Dispos, 2021, 49(1):53-61

PubMed: 33148688 ( click the link to review the publication )

Mol Cell, 2020, 80(6):1104-1122.e9

PubMed: 33259812 ( click the link to review the publication )

Nat Protoc, 2020, 15(2):421-449

PubMed: 31932771 ( click the link to review the publication )

Nat Commun, 2020, 11(1):5842

PubMed: 33203880 ( click the link to review the publication )

Nat Commun, 2020, 11(1):5704

PubMed: 33177525 ( click the link to review the publication )

Nat Commun, 2020, 29;11(1):2086

PubMed: 32350249 ( click the link to review the publication )

Genome Med, 2020, 18;12(1):17

PubMed: 32070411 ( click the link to review the publication )

Gut Microbes, 2020, 12(1):1-20

PubMed: 33006494 ( click the link to review the publication )

Cancers (Basel), 2020, 27;12(5)pii: E1087

PubMed: 32349331 ( click the link to review the publication )

Cancers (Basel), 2020, 13;12(2) pii: E436

PubMed: 32069833 ( click the link to review the publication )

PLoS Pathog, 2020, 16;16(3):e1008341

PubMed: 32176725 ( click the link to review the publication )

Cell Death Dis, 2020, 11(10):831

PubMed: 33024087 ( click the link to review the publication )

FASEB J, 2020, 34(3):3773-3791

PubMed: 31945226 ( click the link to review the publication )

Aging (Albany NY), 2020, 7;12(9):8221-8240

PubMed: 32379705 ( click the link to review the publication )

J Cell Sci, 2020, 14;133(9) pii: jcs240077

PubMed: 32198280 ( click the link to review the publication )

Int J Mol Sci, 2020, 21(23)E9276

PubMed: 33291786 ( click the link to review the publication )

Cancer Cell Int, 2020, 19;20:58

PubMed: 32099531 ( click the link to review the publication )

J Tissue Eng Regen Med, 2020, 14(4):575-587

PubMed: 32061178 ( click the link to review the publication )

Oncol Rep, 2020, 44(6):2581-2594

PubMed: 33125153 ( click the link to review the publication )

Hum Cell, 2020, 10.1007/s13577-020-00420-z

PubMed: 32870449 ( click the link to review the publication )
Hum Cell, 2020, 10.1007/s13577-020-00425-8

PubMed: 32886306 ( click the link to review the publication )

Exp Neurol, 2020, 328:113272

PubMed: 32142802 ( click the link to review the publication )

Blood Adv, 2020, 4(24):6106-6116

PubMed: 33351104 ( click the link to review the publication )

FEBS Lett, 2020, 10.1002/1873-3468.14008

PubMed: 33249578 ( click the link to review the publication )

J Immunother Cancer, 2020, 8(1):e000285

PubMed: 32581055 ( click the link to review the publication )

Nat Cell Biol, 2019, 21(6):778-790

PubMed: 31160710 ( click the link to review the publication )

J Clin Invest, 2019, 129(3):1167-1179

PubMed: 30629551 ( click the link to review the publication )

Haematologica, 2019, 10.3324/haematol.2019.215939

PubMed: 31289206 ( click the link to review the publication )

J Cell Biol, 2019, 218(9):3060-3076

PubMed: 31308216 ( click the link to review the publication )

Cancers (Basel), 2019, 11(6)

PubMed: 31181609 ( click the link to review the publication )

J Physiol, 2019, 597(6):1627-1642

PubMed: 30488437 ( click the link to review the publication )

Front Oncol, 2019, 9:586

PubMed: 31428570 ( click the link to review the publication )

Sci Rep, 2019, 9(1):5309

PubMed: 30926929 ( click the link to review the publication )

Mol Carcinog, 2019, 10.1002/mc.23139

PubMed: 31777985 ( click the link to review the publication )

Molecules, 2019, 24(3)

PubMed: 30754629 ( click the link to review the publication )

Leuk Lymphoma, 2019, 60(1):189-199

PubMed: 29741440 ( click the link to review the publication )

Exp Hematol, 2019, 77:36-40.e2

PubMed: 31493432 ( click the link to review the publication )

BMC Complement Altern Med, 2019, 19(1):105

PubMed: 31113420 ( click the link to review the publication )

Drugs R D, 2019, 19(2):149-166

PubMed: 30919310 ( click the link to review the publication )

Oncotarget, 2019, 10(23):2237-2251

PubMed: 31040916 ( click the link to review the publication )

Leuk Res, 2019, 78:36-44

PubMed: 30711891 ( click the link to review the publication )

Anat Rec (Hoboken), 2019, 302(12):2193-2200

PubMed: 31569304 ( click the link to review the publication )

Cancer Res, 2018, 78(22):6497-6508

PubMed: 30262461 ( click the link to review the publication )

Cancers (Basel), 2018, 10(12)

PubMed: 30572654 ( click the link to review the publication )
Pigment Cell Melanoma Res, 2018, 31(2):253-266

PubMed: 28972303 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(12):2622-2632

PubMed: 30282811 ( click the link to review the publication )

Mol Biol Cell, 2018, 10.1091/mbc.E18-08-0496

PubMed: 30303751 ( click the link to review the publication )

Biochem Pharmacol, 2018, 156:248-264

PubMed: 30142322 ( click the link to review the publication )

Int J Mol Sci, 2018,

PubMed: 29933569 ( click the link to review the publication )

Int J Oncol, 2018, 53(4):1544-1556

PubMed: 30066854 ( click the link to review the publication )

Transl Oncol, 2018, 11(6):1406-1418

PubMed: 30219696 ( click the link to review the publication )

Onco Targets Ther, 2018,

PubMed: 29695913 ( click the link to review the publication )

J Neurol Sci, 2018, 391:90-99

PubMed: 30103978 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 502(1):110-115

PubMed: 29787755 ( click the link to review the publication )

Nat Commun, 2017, 1;8(1):1232

PubMed: 29089541 ( click the link to review the publication )

Elife, 2017, 6

PubMed: 28199182 ( click the link to review the publication )

Arch Toxicol, 2017, 91(8):2921-2938

PubMed: 28032146 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(11):2563-2571

PubMed: 28839001 ( click the link to review the publication )

Mol Cancer Ther, 2017, pii: molcanther.0669

PubMed: 28223426 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(9):1989-1998

PubMed: 28637715 ( click the link to review the publication )

Transl Lung Cancer Res, 2017, 6(5):600-610

PubMed: 29114475 ( click the link to review the publication )

Biochim Biophys Acta, 2017, 1864(2):440-448

PubMed: 27913209 ( click the link to review the publication )

Cell Host Microbe, 2017, 21(6):754-768

PubMed: 28618271 ( click the link to review the publication )

Cancer Res, 2016, 76(23):6937-6949

PubMed: 27758892 ( click the link to review the publication )

Mol Cancer Ther, 2016, 10.1158/1535-7163

PubMed: 27196758 ( click the link to review the publication )

J Neurochem, 2016, 139(4):610-623

PubMed: 27507246 ( click the link to review the publication )

Int J Oncol, 2016, 49(1):402-10

PubMed: 27120977 ( click the link to review the publication )

Hum Mol Genet, 2015, 24(15):4296-305

PubMed: 25948553 ( click the link to review the publication )
Biochem J, 2015, 465(2):271-9

PubMed: 25351958 ( click the link to review the publication )

BMC Genomics, 2015, 16 Suppl 12:S2

PubMed: 26681397 ( click the link to review the publication )

Neuroscience, 2015, 304:316-27

PubMed: 26235435 ( click the link to review the publication )

Neurotox Res, 2015, 27(4):384-98

PubMed: 25782580 ( click the link to review the publication )

Oncotarget, 2015,

PubMed: 26325669 ( click the link to review the publication )

Drug Metab Dispos, 2014, 42(11):1851-7

PubMed: 25165131 ( click the link to review the publication )

Mol Hum Reprod, 2014, 10.1093/molehr/gau073

PubMed: 25180269 ( click the link to review the publication )

PLoS One, 2014, 9(1):e87014

PubMed: 24466315 ( click the link to review the publication )

PLoS One, 2014, 9(10):e111534

PubMed: 25356636 ( click the link to review the publication )

Pharmacogenet Genomics, 2014, 24(1):52-61

PubMed: 24322003 ( click the link to review the publication )

Anticancer Res, 2014, 34(4):1629-35

PubMed: 24692691 ( click the link to review the publication )

Blood, 2013, 122(7):1203-13

PubMed: 23836556 ( click the link to review the publication )

Mol Hum Reprod, 2013, 19(9):570-80

PubMed: 23630234 ( click the link to review the publication )

Pharmgenomics Pers Med, 2013, 6:63-72

PubMed: 24019750 ( click the link to review the publication )

Cancer Res, 2012, 72(5):1229-38

PubMed: 22241084 ( click the link to review the publication )

Mol Cell Biol, 2012, 32(2):320-32

PubMed: 22037769 ( click the link to review the publication )

Blood, 2011, 118(7):1885-98

PubMed: 21680801 ( click the link to review the publication )

Cancer Res, 2010, 70(19):7489-99

PubMed: 20709760 ( click the link to review the publication )

J Virol, 2010, 85(5):2296-303

PubMed: 21177802 ( click the link to review the publication )

J Biol Chem, 2010, 285(11):7977-85

PubMed: 20068039 ( click the link to review the publication )

Purity & Quality Control

Choose Selective Src Inhibitors

Biological Activity

Description

Targets

S6 kinase ^[7] ()	ERK ^[7] ()	STAT3 ^[7] ()	Abl ^[2] (Cell-free assay)	Src ^[1] (Cell-free assay)
			1 nM	1.2 nM

In vitro

Bosutinib is selective for Src over non-Src family kinases with an IC50 of 1.2 nM, and potently inhibits Src-dependent cell proliferation with an IC50 of 100 nM. ^[1] Bosutinib significantly inhibits the proliferation of Bcr-Abl-positive leukemia cell lines KU812, K562, and MEG-01 but not Molt-4, HL-60, Ramos, and other leukemia cell lines, with IC50 of 5 nM, 20 nM and 20 nM, respectively, more potently than that of STI-571. Similar to STI-571, Bosutinib displays antiproliferative activity against the Abl-MLV-transformed fibroblasts with IC50 of 90 nM. Bosutinib ablates tyrosine phosphorylation of Bcr-Abl and STAT5 in CML cells and of v-Abl expressed in fibroblasts at the concentration of ~50 nM, 10-25 nM and 200 nM, respectively, leading to the Bcr-Abl downstream signaling inhibition of Lyn/Hck phosphorylation. ^[2] Although unable to inhibit the proliferation and survival of breast cancer cells, Bosutinib significantly decreases the motility and invasion of breast cancer cells with IC50 of ~250 nM, involved with an increase in cell-to-cell adhesion and membrane localization of β-catenin. ^[3]

Cell Data

Cell Lines	Assay Type	Incubation Time	Activity Description	PMID
NB7	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnnYTWM2OD1yLkC4NlMyKCEQvF2=	MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SW756	MnLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NYrGbHg6UUN3ME2wMlE1ODJ2IDFOwG0>	NI\WUWg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
CTV-1	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NI[xb2NKSzVyPUCuNVY{QThiIN88US=>	NFL4coc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HSC-4	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXPJR\|UxRTBwMUexOVghKM7:TR?=	M1rrXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
LAMA-84	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1K3SGlEPTB;MD6yPFY3PCBizszN	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KU812	NFTNT5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYO3[XR2UUN3ME2wMlM1ODZ6IDFOwG0>	NFrYblU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HCC1806	NX[0foNtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{mw[GlEPTB;MD6zOVIyPiBizszN	MonMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
DOK	NIjTSVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NVXXcHNtUUN3ME2wMlM4Pzh4IDFOwG0>	MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H209	NV\HZVFIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2rwd2lEPTB;MD60NFgxQCBizszN	M3nUTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EoL-1-cell	MmXRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MoSzTWM2OD1yLkSxOVc3KCEQvF2=	MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
H9	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NI\0fFVKSzVyPUCuOFM1PjRiIN88US=>	MnKzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EM-2	M3jTXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NIKyOZFKSzVyPUCuOFM5QSBizszN	NUHwcZZURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H292	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUPJR\|UxRTBwNESxNFghKM7:TR?=	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
697	NIPSV5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGrEOHlKSzVyPUCuOFU3OzNiIN88US=>	NF3OflU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
BHT-101	NXfZVHhvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlHoTWM2OD1yLkS2OVkhKM7:TR?=	MlTFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
BE-13	MmXWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnG2TWM2OD1yLkS4OVczKCEQvF2=	MkfIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
RS4-11	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmPQTWM2OD1yLkS4OVg1KCEQvF2=	NVThWHozRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
IGROV-1	MnHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4XzemlEPTB;MD60PFc6PyBizszN	M2fKcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KE-37	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MlGyTWM2OD1yLkS5OVA6KCEQvF2=	NXPidVQ5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
BV-173	M4TvdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M2L2OWlEPTB;MD61NFc6OiBizszN	NETlVHo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MEG-01	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmLuTWM2OD1yLkWxNlE1KCEQvF2=	Mn7YQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
LB2241-RCC	NW\ZeIhwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2jtSWlEPTB;MD61N\|cyQCBizszN	M1HaSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ACHN	NHjSUlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYfaVm5HUUN3ME2wMlU1ODZ7IDFOwG0>	M2TW[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CTB-1	MoXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MmDpTWM2OD1yLkW0PFIhKM7:TR?=	Mn6zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HT-1080	M{\LOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NIjzSmVKSzVyPUCuOVU{PDliIN88US=>	NX3ISVJKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
CHL-1	NUXpfm55T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXLJR\|UxRTBwNUW0OlUhKM7:TR?=	MonIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EW-3	M322cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3LPS2lEPTB;MD61OVk{PSBizszN	NInhNlk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ES1	MmjIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MXrJR\|UxRTBwNke0PVghKM7:TR?=	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KASUMI-1	M3THZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3XBS2lEPTB;MD63NlM{KCEQvF2=	NUj1PGpXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SW13	NXvwcY5nT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWjJR\|UxRTBwN{O3PVghKM7:TR?=	NWLiN4tQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
A3-KAW	MlHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MVTJR\|UxRTBwN{myNFghKM7:TR?=	NYn3ZYJzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LB771-HNC	NEnCV2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUPJR\|UxRTBwOEOxNFQhKM7:TR?=	NWDiUGptRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
OC-314	NGW0V29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NW\BUJlqUUN3ME2wMlg3QTZ3IDFOwG0>	M3nwdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MLMA	M2nGbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmXBTWM2OD1yLkmwOlc2KCEQvF2=	M3zWclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KARPAS-45	NWnReHZqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIPEZ3NKSzVyPUCuPVI1PjZiIN88US=>	M3[4dVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CAL-27	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnHFTWM2OD1yLkmyPVA3KCEQvF2=	Mm[xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-NEP-1	NWTaNpFOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXfJR\|UxRTBwOUeyOFghKM7:TR?=	M2DHZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
COR-L105	M1fjXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHXMdpZKSzVyPUGuNFA{QTRiIN88US=>	MkLaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
TI-73	NVvNXGtCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWOzcpBSUUN3ME2xMlAyPjViIN88US=>	M4\CdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
JVM-3	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NITtfnJKSzVyPUGuNFUxOTdiIN88US=>	Mn;GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HAL-01	M4f1RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NF60VnRKSzVyPUGuNFg5OSBizszN	NFrOZ209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
QIMR-WIL	MofhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWXJR\|UxRTFwMEmwOVghKM7:TR?=	NXm2d29sRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HSC-3	MmfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEnUUJBKSzVyPUGuNVE4QDNiIN88US=>	NInj[mc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KY821	MmKzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHTZeo1KSzVyPUGuNVM{PTFiIN88US=>	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
5637	MmLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnzWTWM2OD1zLkGzPFA{KCEQvF2=	M17UN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CAL-33	MlL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnXQTWM2OD1zLkG5N\|AzKCEQvF2=	MlfWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ES4	MojWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFG5T3pKSzVyPUGuNlA4QSBizszN	NX;hW4o2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
BHY	MlHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mn:4TWM2OD1zLkKyPFkzKCEQvF2=	MlfLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
LB1047-RCC	NH:zO21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlnsTWM2OD1zLkKzO\|g2KCEQvF2=	NFXrV\|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
H4	MlfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{KyWWlEPTB;MT6yOFI2PSBizszN	M3vObFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
RPMI-8866	M3TzOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{HpOGlEPTB;MT6yOlExPiBizszN	MkD5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HO-1-N-1	M3vK[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mon3TWM2OD1zLkK2N\|Y6KCEQvF2=	MnLvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
BB30-HNC	MoG5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlXMTWM2OD1zLkK4O\|E1KCEQvF2=	NFjHSIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
PC-14	NH2zUXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NEfHeZZKSzVyPUGuNlkzODViIN88US=>	NES5XpA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NUGC-3	MlTwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXXkbnRxUUN3ME2xMlI6OzV4IDFOwG0>	M3LYN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
A4-Fuk	NYS2Z\|ZGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4nRd2lEPTB;MT6zNFcxPCBizszN	NIXSVIE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MHH-NB-11	NWjv[Hp{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{\Hd2lEPTB;MT6zNVM5OyBizszN	NXmxdld3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KOSC-2	NWn4WVRLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3HMRmlEPTB;MT6zNVc4PSBizszN	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A498	M4DEd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFjiSIFKSzVyPUGuOFAyOTNiIN88US=>	M1LTe\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KG-1	M{fINGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVLJR\|UxRTFwNEGyO\|MhKM7:TR?=	NYfaS4RzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
DEL	NVXzZoZET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWnJR\|UxRTFwNEO2OVchKM7:TR?=	NYXSe\|h6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
EW-16	M3jPc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXvZbFRsUUN3ME2xMlQ{QTd\|IDFOwG0>	NYPHSY1mRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
BPH-1	MkHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYDJR\|UxRTFwNES4NFUhKM7:TR?=	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
JAR	NUDWcVZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3fnfmlEPTB;MT60PVM3KCEQvF2=	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
J-RT3-T3-5	MnH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NF\5[ohKSzVyPUGuOVE4OjJiIN88US=>	NGfveZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A375	MkK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWe2R\|UzUUN3ME2xMlUyPzd{IDFOwG0>	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SW954	NGrDVmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3\UOGlEPTB;MT61OVAxPyBizszN	NEm0fpc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
Ca9-22	M2frV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NGTGU4lKSzVyPUGuOVYzPiBizszN	M3u5UlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
D-566MG	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NHK1PFFKSzVyPUGuOVcyPTViIN88US=>	NFftV2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SCC-15	NGHPUWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2GwcWlEPTB;MT62NVgxPCBizszN	NV30dJFyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HD-MY-Z	Mn7XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NY\3epd4UUN3ME2xMlY{PTh2IDFOwG0>	Ml\qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HT-1376	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1iwZ2lEPTB;MT62OFM3KCEQvF2=	M3uzfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CAL-54	M1TZPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M2nod2lEPTB;MT62OVcxQSBizszN	M3;iPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ONS-76	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmTaTWM2OD1zLk[3OVUyKCEQvF2=	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
EFO-27	NFrzNFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4f1WmlEPTB;MT62PFkzKCEQvF2=	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
769-P	M3qzNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3z4OWlEPTB;MT62PVU6PiBizszN	M134d\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MV-4-11	MmnBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWnOVYxwUUN3ME2xMlY6QDV4IDFOwG0>	Mo\QQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NKM-1	M2nHV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3rZbGlEPTB;MT63NVgxOiBizszN	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
LOXIMVI	MnfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MmXGTWM2OD1zLke0OVk6KCEQvF2=	NEnGcoQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KYSE-140	M4LHW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Ml7lTWM2OD1zLke1OlU2KCEQvF2=	Ml7zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ES5	NVWweFdMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYnJR\|UxRTFwOE[3OFchKM7:TR?=	NVH1OGR4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
BB65-RCC	MkjCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3nUNGlEPTB;MT64PVg1QSBizszN	M2TBW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HN	M3HUcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mn;mTWM2OD1zLki5PFc1KCEQvF2=	NE\PUZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A101D	NED3SWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnrzTWM2OD1zLkmzOlI5KCEQvF2=	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
LoVo	NXj4eplJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NW\wb3JSUUN3ME2xMlk4Pjd7IDFOwG0>	M33qNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H526	NEW4c21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2ThPGlEPTB;MT65PVMzPSBizszN	M17FdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H1693	M1K2bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NF35eWJKSzVyPUGuPVk5QDhiIN88US=>	NXWxNnhqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
OVCAR-4	MkG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWXJR\|UxRTJwMEC0N\|UhKM7:TR?=	MkXYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-HEP-1	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVPJR\|UxRTJwMEC3OFUhKM7:TR?=	MlXGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
C2BBe1	NYL5Z5d4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHHybWJKSzVyPUKuNFM{PzJiIN88US=>	NYTye5RURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MEL-JUSO	NWXqToNpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIjDPIVKSzVyPUKuNFQ1PjRiIN88US=>	NX\EVIxKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MOLT-16	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVTxfZgxUUN3ME2yMlA4ODV6IDFOwG0>	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NBsusSR	M2jNemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NGfYVXhKSzVyPUKuNFk5QDliIN88US=>	NY\yeW1HRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TK10	Mon2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{W2ZWlEPTB;Mj6xN\|Q2QCBizszN	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
CAL-39	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVjJR\|UxRTJwMUS0PEAh\|ryP	MnfPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H2030	MkL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MVPJR\|UxRTJwMUi5O\|MhKM7:TR?=	NIWx[JU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HCT-116	M1rO[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MlfmTWM2OD1{LkKyPVg1KCEQvF2=	NYTQN3l5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HTC-C3	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MofUTWM2OD1{LkK2PFI1KCEQvF2=	NXnjSIl1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TYK-nu	NUPDd3liT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{PvXGlEPTB;Mj6zNFkxQSBizszN	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
FADU	M4rWcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXHJR\|UxRTJwM{KyPVYhKM7:TR?=	M{PHb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
A431	NIrPWYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXjJR\|UxRTJwM{ewNlUhKM7:TR?=	NGD4OIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
TE-11	NIrVXJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NEHhZnZKSzVyPUKuN\|gxOTliIN88US=>	NHnIcXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
CAL-12T	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYDiT5lrUUN3ME2yMlQxPDF5IDFOwG0>	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
DB	NF3qVnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NVPtRo1MUUN3ME2yMlQzQDZ7IDFOwG0>	NVHjNm9PRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
L-363	NELh[\|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkHxTWM2OD1{LkSzOVA4KCEQvF2=	Mk\iQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MSTO-211H	M3XZeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NETYRYZKSzVyPUKuOlY{QTFiIN88US=>	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-UT-1	NF3nflRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYjob5BwUUN3ME2yMlcyPDB4IDFOwG0>	NFnQWXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
RPMI-8226	MmezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MkLGTWM2OD1{LkezNVY1KCEQvF2=	M1;qOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SF295	NV7CZpJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUTJR\|UxRTJwN{SzNUAh\|ryP	NHvTRmQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
OS-RC-2	M1jjVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MkPqTWM2OD1{Lke2Olc{KCEQvF2=	M4PoO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SK-MEL-24	NX7VNI1GT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUfJR\|UxRTJwN{iyNlQhKM7:TR?=	NHrsV\|U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
COR-L23	MofhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3voR2lEPTB;Mj63PVQ3PCBizszN	MkTIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MHH-PREB-1	M4m2ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFXaXWdKSzVyPUKuPFAyPjFiIN88US=>	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-N-DZ	MlvkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIP0N45KSzVyPUKuPFE3OzhiIN88US=>	NG\LW209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
OMC-1	NI\FcpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MoTxTWM2OD1{Lki1NFA{KCEQvF2=	NWriR4ZSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SK-MEL-2	NYTXUFBWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWTsTotwUUN3ME2yMlg6OjR\|IDFOwG0>	M{O4eVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SAS	Mon3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NG\UUWZKSzVyPUKuPVk1OTViIN88US=>	M3TrcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EPLC-272H	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXTJR\|UxRTNwMECyN\|UhKM7:TR?=	M2DjOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
8505C	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NUHXWFJWUUN3ME2zMlExOzBzIDFOwG0>	NYHveJA4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
EW-11	NFLmVWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXfJR\|UxRTNwMUSyO\|chKM7:TR?=	M{LNPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
YKG-1	Mon1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4rqbWlEPTB;Mz6xOFcxPiBizszN	NWfQeppSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
EC-GI-10	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MWLJR\|UxRTNwMUeyOlMhKM7:TR?=	NInTcpc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SK-LU-1	MnfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NV;vRVZWUUN3ME2zMlE5PDF6IDFOwG0>	NYLOcGV[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
P30-OHK	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NU\sWZB4UUN3ME2zMlIxOTF5IDFOwG0>	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
T-24	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MULJR\|UxRTNwMkG4NVQhKM7:TR?=	M2P1fFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HSC-2	NXn3elNxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlHJTWM2OD1\|LkKyNlMzKCEQvF2=	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-MES-1	NGTZXFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYHrZpFqUUN3ME2zMlI1QDJ7IDFOwG0>	M4G4dlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SW48	M2n0Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MoPiTWM2OD1\|LkK1OFg3KCEQvF2=	NUTjOlJVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
ME-180	M4XjbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3;SXGlEPTB;Mz6yOlA2OSBizszN	NF;YSYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H2009	M1fOPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEC1d\|FKSzVyPUOuNlkxOSBizszN	NFvjUW89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HL-60	MknES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NUjzUHlYUUN3ME2zMlI6OTNiIN88US=>	MlHTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-N87	NWjWO4ppT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIX0U41KSzVyPUOuN\|AyPzJiIN88US=>	MmPZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
GMS-10	NGLpVnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlvKTWM2OD1\|LkO0NFg3KCEQvF2=	M3rZdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SCH	NX7DUHNET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{\tfmlEPTB;Mz60NFg1PCBizszN	Mnn2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
C-33-A	NWiybVhoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWrJR\|UxRTNwNEG0NlEhKM7:TR?=	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1703	MlvtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1e5VmlEPTB;Mz60NVgyOiBizszN	M1rEU\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
A427	M3\PUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{TURmlEPTB;Mz60OlEzPCBizszN	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MOLT-4	NFHjPWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{W3dmlEPTB;Mz60PFE6QSBizszN	M4\ad\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H1792	MknLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1TxO2lEPTB;Mz60PVgxOiBizszN	MmrvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1650	MlmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MUDJR\|UxRTNwNUeyPUAh\|ryP	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
H-EMC-SS	NEPjbFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWrRZ3V{UUN3ME2zMlU5PTZ7IDFOwG0>	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SW982	M{XpNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4HtT2lEPTB;Mz61PFgzQSBizszN	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
DSH1	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MX7JR\|UxRTNwNkSxNlIhKM7:TR?=	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NOS-1	Ml\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFnteXVKSzVyPUOuOlQzPzZiIN88US=>	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BT-549	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVfJR\|UxRTNwNke4OVQhKM7:TR?=	NWrqdmo1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HuCCT1	M1rLWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NGL5VYVKSzVyPUOuO\|QyPzdiIN88US=>	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1755	M2rNN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEHucotKSzVyPUOuPVY6PzFiIN88US=>	NEHpWVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KYSE-450	MoOyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MknMTWM2OD1\|Lkm2PVk4KCEQvF2=	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MIA-PaCa-2	M3\kRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFztV4ZKSzVyPUOuPVczQSBizszN	M4niN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
U-266	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mm\tTWM2OD1\|Lkm3OFgyKCEQvF2=	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
Mewo	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV\JR\|UxRTRwME[zOlEhKM7:TR?=	NUjIPFJGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KYSE-520	NILTWlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYToTGxrUUN3ME20MlA6Pzl7IDFOwG0>	NF3Td4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MN-60	M{Tiemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M2C0Z2lEPTB;ND6xNFUxOSBizszN	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
Ramos-2G6-4C10	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NFSwZVVKSzVyPUSuNVY4OzliIN88US=>	MlHwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-MEL-1	Mlf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHXKUYhKSzVyPUSuNVg3QTViIN88US=>	M{f1elxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ABC-1	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MULJR\|UxRTRwMkOzN\|MhKM7:TR?=	NVzwNlZ7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
CAKI-1	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1nvOWlEPTB;ND6yOFU4OSBizszN	M1Xn[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HOS	NGD4UFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2rPNGlEPTB;ND6yPVE1OSBizszN	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SN12C	NE\jeIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWqz[YRxUUN3ME20MlM1OjR2IDFOwG0>	MknvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NB13	MkjXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mkf4TWM2OD12LkO3N\|U2KCEQvF2=	MkjrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
M14	NU[2e5BTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M333SGlEPTB;ND60PFc6OiBizszN	M3nhUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
GP5d	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NUDPOlN5UUN3ME20MlUxOTJiIN88US=>	NUmyfVlpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H720	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Ml[zTWM2OD12LkWzOlEzKCEQvF2=	Mlr3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
D-423MG	M1PiT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3HDdGlEPTB;ND61N\|kzPCBizszN	MnLDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ChaGo-K-1	NImzUotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlSwTWM2OD12LkW5OVU6KCEQvF2=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MEL-HO	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MULJR\|UxRTRwNkGyOlEhKM7:TR?=	NGOzd3E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MHH-ES-1	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYPGdFZ7UUN3ME20MlYzPDFzIDFOwG0>	NUToboljRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KYSE-270	M4rUV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXy4PGtvUUN3ME20MlY2OTJ4IDFOwG0>	M1GwSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
GI-ME-N	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1PEd2lEPTB;ND63NVI6OSBizszN	NYP4VIlZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HOP-92	MkjlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFHNTIJKSzVyPUSuPFE{PzliIN88US=>	NFv2TWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MKN1	MlHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MV\JR\|UxRTRwOEO5NVQhKM7:TR?=	M2\t[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ML-2	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1XEeGlEPTB;ND64OVYzPiBizszN	M2L2ZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
RO82-W-1	NG\VVmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGPlTFNKSzVyPUSuPVI6QCBizszN	NX76[5JrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
G-361	NXT5VI9DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVPJR\|UxRTVwMEGwNFMhKM7:TR?=	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HC-1	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NFLZbYVKSzVyPUWuNFMzQTFiIN88US=>	M1\BflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EW-24	NH;4e3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVPJR\|UxRTVwMESwN\|ghKM7:TR?=	MkjoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HuP-T4	NYGzdYNvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIfVT4VKSzVyPUWuNVQ{OzRiIN88US=>	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
8-MG-BA	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Ml\ZTWM2OD13LkO0NlghKM7:TR?=	Mn;CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HGC-27	MkTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVexZ4VTUUN3ME21MlM4Pjh{IDFOwG0>	NETGNIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
TE-12	M1e2UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NI\CUVdKSzVyPUWuOFE2QDViIN88US=>	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GT3TKB	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4n3O2lEPTB;NT60OFIyOiBizszN	M3:xfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
DOHH-2	NI\ZcHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUjsblhPUUN3ME21MlQ2QTh4IDFOwG0>	M1XoblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
Ca-Ski	Mkn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MljzTWM2OD13LkS2NVE2KCEQvF2=	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A172	NHvBbVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NF;3eHJKSzVyPUWuOVQ6OjViIN88US=>	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
EGI-1	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4TB[2lEPTB;NT61PFk{QCBizszN	M2nmeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MZ2-MEL	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NXLC[WxIUUN3ME21MlYyPDh4IDFOwG0>	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SW1710	NIrpeoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX;kZWRCUUN3ME21MlY6ODlzIDFOwG0>	NHrOR3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HT-144	M3K4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHvXU3NKSzVyPUWuO\|I3QDViIN88US=>	NVXrT4hmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
PA-1	MoPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NETZe5dKSzVyPUWuPFE5QTNiIN88US=>	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HCC1937	NF2zRZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkT2TWM2OD13LkizPVI6KCEQvF2=	MlXCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-OV-3	M1XUb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVTJR\|UxRTVwOUGxNlEhKM7:TR?=	M{LuZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
K5	NYf1dVNLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MorRTWM2OD14LkC1NVchKM7:TR?=	MmjDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NMC-G1	NFrQOIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUHUOnc4UUN3ME22MlA4Pzl5IDFOwG0>	NXG2O2RCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MDA-MB-361	NVjNU4szT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4TtUmlEPTB;Nj6wPVI3OSBizszN	NHroOGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
EKVX	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1PZTGlEPTB;Nj6xN\|UxOSBizszN	NHf1ZW09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ES7	M{\QPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NH3hOI9KSzVyPU[uNVYyOTViIN88US=>	NIHRVlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KS-1	NWq3TmwyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVzJR\|UxRTZwMUe5PVMhKM7:TR?=	NUjIbHdSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H661	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3Xlc2lEPTB;Nj6xPFA5OSBizszN	M{O4cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ES8	MlK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWPJR\|UxRTZwMUiwPFIhKM7:TR?=	MkC3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H23	MoC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{\uWmlEPTB;Nj6yNVgyPiBizszN	NI[xXnQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
T47D	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NH\CZotKSzVyPU[uNlY1PTdiIN88US=>	MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A2780	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NX7GZ2VwUUN3ME22MlM4PzBzIDFOwG0>	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SCC-4	MoXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MXnJR\|UxRTZwNEO1OlEhKM7:TR?=	MlzHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
VA-ES-BJ	NHrKWVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MmTpTWM2OD14Lkm3NFQ{KCEQvF2=	NFTud209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
no-11	M4j5SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{\TR2lEPTB;Nz6xOlQyKCEQvF2=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KU-19-19	NIH5dGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXeyW5lsUUN3ME23MlE3PDd4IDFOwG0>	MoL6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MKN45	NG\hdmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NInEN\|FKSzVyPUeuNVg3QTliIN88US=>	NUfmU\|BqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SCC-25	NHXYN41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUfOZpdmUUN3ME23MlI{PDF2IDFOwG0>	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ETK-1	M3vPUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmTNTWM2OD15LkK1OVE1KCEQvF2=	NEPDN\|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
COR-L88	Mm[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWnqZXFMUUN3ME23MlI6OzF7IDFOwG0>	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
8305C	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NXfoOJZ5UUN3ME23MlMzPDl{IDFOwG0>	NGe5eFk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
Detroit562	M2m4UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1fGNmlEPTB;Nz6zNlUxPiBizszN	NYDzNmxORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SNU-449	NFy1TodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYnJc2x[UUN3ME23MlM4PjVzIDFOwG0>	NInF[lA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A704	NFz6V4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX\jbXRsUUN3ME23MlM5Ojd6IDFOwG0>	NGqyR3U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
D-502MG	M{TO[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVnJR\|UxRTdwM{i0O\|MhKM7:TR?=	M3q4dlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H2228	M{Hibmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M13PeWlEPTB;Nz60NVQ2QCBizszN	MnfQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
CHP-212	NXTlfJR7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2\NdWlEPTB;Nz61NVg6PiBizszN	NFztdI89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
VMRC-RCZ	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnniTWM2OD15LkW5NFY3KCEQvF2=	NGP0cGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
RPMI-2650	NUjhToZDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NGfLe2pKSzVyPUeuO\|A{OTJiIN88US=>	NILJV3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HCC2218	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2HFfmlEPTB;Nz63NlI2QCBizszN	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GCT	NFiyeWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MULJR\|UxRTdwOEKxO\|IhKM7:TR?=	NXLpd2xtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SW780	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGPFPGdKSzVyPUeuPVkxPiBizszN	NFX3cGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KMOE-2	MlrBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NYnERZd{UUN3ME24MlA1ODdiIN88US=>	Mm[yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KYSE-180	NGHQR2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1PYfmlEPTB;OD6wPFY1QCBizszN	NX\0e3c1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TE-1	M2Lwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWDJR\|UxRThwMUGwOVchKM7:TR?=	NFjQOZQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
OAW-42	NFj2UGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1nqVWlEPTB;OD6yOVQ6PiBizszN	MlXZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
VM-CUB-1	M1XLUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NITo[VNKSzVyPUiuNlg{PjRiIN88US=>	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ECC10	NEDo[JRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NITIRoRKSzVyPUiuNlg{QTdiIN88US=>	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SW1573	NFn5UJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1\KSmlEPTB;OD60OFQ3PSBizszN	NFPOU2w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1299	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmW3TWM2OD16LkW5O\|c1KCEQvF2=	M331WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ALL-PO	NXrMS295T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NI\GbldKSzVyPUiuOlY2QTdiIN88US=>	MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
OVCAR-5	NFzZU2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3Hz[GlEPTB;OD63O\|YzPSBizszN	NXyzU2syRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-SNU-5	NUO1fZdTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{\YNWlEPTB;OD64N\|AxOSBizszN	MlrUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H2342	MlK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MkTQTWM2OD16LkizNVAyKCEQvF2=	NUnzemtXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
RPMI-7951	NFzBbFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkXtTWM2OD16Lki0NVU4KCEQvF2=	NV\5N2JDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
RCM-1	NXHzUVM4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NV6zbpJ3UUN3ME25MlA5OTR3IDFOwG0>	M2K2R\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
Daoy	NXzJRXJVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVrxVndEUUN3ME25MlEzODJ6IDFOwG0>	NFrheGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HCC1395	Ml;BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{jDN2lEPTB;OT6zNFg6PiBizszN	MmPnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
786-0	M1LoPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MV\JR\|UxRTlwM{[wNlYhKM7:TR?=	NFnNXmo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
GAMG	M1\aZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnHETWM2OD17Lk[1OVM1KCEQvF2=	M{LDSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HCC1954	MkjBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVXqfog2UUN3ME25Mlg2QDV7IDFOwG0>	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1838	M3WxcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEnpZYJKSzVyPUmuPVA{PzFiIN88US=>	M1nMOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SW620	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnzGTWM2OD17Lkm1N\|U4KCEQvF2=	NE\GfY89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H358	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYTQcJJ[UUN3ME2xNE41OTl5IDFOwG0>	Mn\2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1793	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3fr[2lEPTB;MUCuOFI1QCBizszN	MlTGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1666	Mnq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWPnT5NvUUN3ME2xNE41OzV3IDFOwG0>	NXvDN4ZVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MZ7-mel	NVzJUXM{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWezXmZkUUN3ME2xNE41PzV\|IDFOwG0>	NH3tNlk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MDA-MB-175-VII	MmP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MU\JR\|UxRTFyLk[zPVYhKM7:TR?=	NHz5OIg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
COLO-829	NHPUNVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MX;JR\|UxRTFyLkiwNFQhKM7:TR?=	MmTnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
RVH-421	NUe5VWdRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NH:5RmVKSzVyPUGxMlE2OiBizszN	Mnf5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
A549	MmXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MUDJR\|UxRTFzLkK0O\|ghKM7:TR?=	NHTaZZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
DJM-1	NX\zS5Y5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NH;CWFNKSzVyPUGxMlM5OzNiIN88US=>	MlPkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
IST-MEL1	NFPCfVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NEW5TI1KSzVyPUGxMlc{OTliIN88US=>	NGHB[WY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
BEN	Mm\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MV\JR\|UxRTFzLke0NFIhKM7:TR?=	NF;ydlQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KM12	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWLx[4hwUUN3ME2xNU46ODlzIDFOwG0>	M33LeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HuO9	NUfDcVZpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYHlV2F1UUN3ME2xNk4xPjZ4IDFOwG0>	NF;QTHQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
U-2-OS	NHHXN21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NH7KNYlKSzVyPUGyMlA5QTNiIN88US=>	NHXITpI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
RH-1	NWLRWZZqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlzmTWM2OD1zMj60OFczKCEQvF2=	NXe1doV6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H1048	M3rUXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{DmS2lEPTB;MUKuOVUxPiBizszN	MnPGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
Mo-T	M2Lndmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Moi3TWM2OD1zMj63N\|A4KCEQvF2=	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KYSE-150	MoPBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXvxN4JrUUN3ME2xNk44PDV3IDFOwG0>	M2D0OlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
A388	MnrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NUPvUVdbUUN3ME2xNk44PzF\|IDFOwG0>	MljyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-SNU-1	M3O0[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NUPVWGU4UUN3ME2xNk45ODR4IDFOwG0>	NUO2dGtNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HEL	MkC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MX\JR\|UxRTF{LkiyNVIhKM7:TR?=	M{DnO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
UM-UC-3	NV;ERmJlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{XtXWlEPTB;MUKuPFg4PCBizszN	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
TGBC24TKB	NYHOXYFvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXf6R5Q6UUN3ME2xN{4xOjZ5IDFOwG0>	MluxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SW626	NUj0fZFJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVrJR\|UxRTF\|LkK0PFUhKM7:TR?=	NH\xdnc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ES6	M2XsPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHnqV5lKSzVyPUGzMlI2OTJiIN88US=>	NGHLXGY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H2029	NFTYTIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnzaTWM2OD1zMz64NVA5KCEQvF2=	M3m4NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
RXF393	NVPiZYo2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NInWdYNKSzVyPUGzMlk6OjdiIN88US=>	M133OVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HMV-II	MmTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{nuSGlEPTB;MUSuNFc5KCEQvF2=	NGG0c4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
EW-22	NEHGTZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHq3eJdKSzVyPUG0MlE2ODJiIN88US=>	NHPOZ5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
AsPC-1	MnHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWnJR\|UxRTF2LkW2OEAh\|ryP	NUTrNlRvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
COLO-678	MlXQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NY\GdlB5UUN3ME2xOE44OjdzIDFOwG0>	M1TvTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HCT-15	Ml\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIDOZ2ZKSzVyPUG0Mlg5PTViIN88US=>	NWTLSZBURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HCE-T	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGnDc2NKSzVyPUG0Mlg5PzRiIN88US=>	NXPlTXVMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SF539	MnnuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHnKeJFKSzVyPUG1MlA3PDNiIN88US=>	M2CwbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
AU565	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NF7ybmJKSzVyPUG1MlIxQTZiIN88US=>	M1PRfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
JVM-2	M3uwfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFLHZ5RKSzVyPUG1MlI3QDFiIN88US=>	NFOxVno9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
CaR-1	MoHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVK0NGNwUUN3ME2xOU41PDF{IDFOwG0>	NXfSUZN1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
23132-87	NFLOb2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYPJR\|UxRTF3Lki0PVUhKM7:TR?=	NFjxdFc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A673	Ml\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3rhdGlEPTB;MUWuPVY{PiBizszN	MonrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KYSE-410	NH\BXoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MmXsTWM2OD1zNj6wNlkhKM7:TR?=	M{fh[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
TE-9	MkPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIrZ[mRKSzVyPUG2MlA3OiBizszN	M4C4SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
LU-139	M{XUe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mn24TWM2OD1zNj6xPFI{KCEQvF2=	MlXWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
GCIY	NUXUO3lYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M1nUbGlEPTB;MU[uNVkyPiBizszN	NWnpV3NHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
JEG-3	NVj4RlZXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHy5bpFKSzVyPUG2MlI2KCEQvF2=	NXrhToVVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
RT-112	NGnifFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkDSTWM2OD1zNj60NVQ{KCEQvF2=	NUnTZ\|FPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
COLO-680N	MofwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFi0XZhKSzVyPUG2MlUyODhiIN88US=>	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
LU-134-A	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXLJR\|UxRTF4Lkm4PVMhKM7:TR?=	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MFM-223	Mki0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWjJR\|UxRTF5LkG1N\|UhKM7:TR?=	NXzubGpNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SF126	NEPteVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGr2[ZFKSzVyPUG3MlE4ODFiIN88US=>	M{TYd\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H28	NXm1N5d2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHu4RVhKSzVyPUG3MlIxPjZiIN88US=>	M3e4clxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
BFTC-905	NXLyR3FbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkHPTWM2OD1zNz60PFMzKCEQvF2=	NXXPVoVqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SCC-9	NEOweVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2rKW2lEPTB;MUeuOlI5PSBizszN	NYLMV5pqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KNS-62	NFnS[mVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NVPPV\|JCUUN3ME2xO{43PjJ7IDFOwG0>	NVrrZ45xRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
Hs-578-T	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MkXVTWM2OD1zNz64NVQ6KCEQvF2=	NXTCbndQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
D-336MG	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MojoTWM2OD1zNz64Nlk1KCEQvF2=	M1nONlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H82	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWnMVGtbUUN3ME2xPE4xOTh\|IDFOwG0>	MmC1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EFM-19	M3LyXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1\kbWlEPTB;MUiuNFU4PyBizszN	MlX5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
TGBC11TKB	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mn\KTWM2OD1zOD6xNFIyKCEQvF2=	MmPuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HEC-1	NXrvbo5mT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4\3VmlEPTB;MUiuNlkyQCBizszN	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HuP-T3	NVqzOG1pT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MoDjTWM2OD1zOD61PVI6KCEQvF2=	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SF268	NY\oUG5LT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MonaTWM2OD1zOD62O\|AzKCEQvF2=	NYL1cW1yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
COLO-792	MlnXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NETVRlJKSzVyPUG4Mlc6QTdiIN88US=>	NXjjPW13RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HLE	NGfpOWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXGyXGJvUUN3ME2xPE45OzNzIDFOwG0>	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A204	NXH6ZpRGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Mmf3TWM2OD1zOD65NVY1KCEQvF2=	MmruQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
CAL-72	NGTZbFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWPEdnFCUUN3ME2xPU4xQDd5IDFOwG0>	M2KwNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
U031	NEPwOIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHzNSY1KSzVyPUG5MlQ6ODliIN88US=>	MoXaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
FTC-133	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MoPuTWM2OD1zOT65N\|A1KCEQvF2=	Mn;xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-MEL-28	M4\UVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVjJR\|UxRTJyLkO3OlEhKM7:TR?=	M4e1[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KGN	MoHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MV;JR\|UxRTJyLkS2PVkhKM7:TR?=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HCC2998	NYHrR4pbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2HGWGlEPTB;MkGuN\|kzPiBizszN	NUnQS25NRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
GOTO	Mm[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4DySmlEPTB;MkGuOFg2KCEQvF2=	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
AGS	NELzdJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIi4eYxKSzVyPUKxMlg1PTFiIN88US=>	M{LjZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EW-13	NFXrfmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MX;JR\|UxRTJ{LkGwNlIhKM7:TR?=	Mlj4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
P12-ICHIKAWA	NF;BdmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXvJR\|UxRTJ{LkG2NFMhKM7:TR?=	Ml3qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1395	NHq1TWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUXZVFZ3UUN3ME2yNk4zQTB5IDFOwG0>	NYDsV5RPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
A2058	MonWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NI\qeG5KSzVyPUKyMlQ{PCBizszN	NYO5W4RbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SH-4	Mlr3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYHJR\|UxRTJ{LkewOFUhKM7:TR?=	Mnj3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
DoTc2-4510	NUTlV2ZZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M17zbGlEPTB;MkOuOlQ4OiBizszN	M2DreFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MMAC-SF	NFHoR2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnTkTWM2OD1{Mz62PVEyKCEQvF2=	NULVWHgxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H510A	M4LSTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXLJR\|UxRTJ\|Lke5N\|khKM7:TR?=	NXzSdGNrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HDLM-2	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MkXYTWM2OD1{ND6xOFYhKM7:TR?=	MkTXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KINGS-1	NW[we2JoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYDJR\|UxRTJ2LkK0NkAh\|ryP	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1648	NVfYOZF1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkLpTWM2OD1{ND60NFI1KCEQvF2=	NIrXflE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HCC1187	NF;k[GtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NV7oSllHUUN3ME2yOU4xOjN3IDFOwG0>	MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BALL-1	NEnkW2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NF[1cHpKSzVyPUK1MlIxPjJiIN88US=>	M1PiU\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SBC-1	M{HZU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWLJR\|UxRTJ3LkK5PVMhKM7:TR?=	NXv1[JQyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
BFTC-909	M4n1RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnjLTWM2OD1{NT6zOVUyKCEQvF2=	M1Hkd\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MOLT-13	M3:5dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXXJR\|UxRTJ3Lk[3OFQhKM7:TR?=	NVnMZXV1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SW1990	M1\Edmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHrG[HBKSzVyPUK1Mlk3PTViIN88US=>	NFTKdpk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
DK-MG	NYLjeZA1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NGDnVI5KSzVyPUK2MlA1PDNiIN88US=>	MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
TE-8	NYDLOVhKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYjGNIJSUUN3ME2yOk4xPjZ6IDFOwG0>	NIDUZYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
Becker	NF\BNG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXHmWWFQUUN3ME2yOk4yPTd2IDFOwG0>	M4LsRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KYSE-70	NF;jclVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUnJR\|UxRTJ4LkWzNVchKM7:TR?=	MmTLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MKN7	NYrOdJBDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MojzTWM2OD1{Nz63OFc6KCEQvF2=	MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
D-392MG	NWDyRnQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWDJR\|UxRTJ5Lke2PVQhKM7:TR?=	NWnRXGdYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NH-12	NYrieoZtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2PDVmlEPTB;MkiuNVIzQSBizszN	M1H1d\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EW-18	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVfJR\|UxRTJ6LkKyNVghKM7:TR?=	NGPLOpE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
LCLC-97TM1	Ml7TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1jFdWlEPTB;MkiuNlc3OiBizszN	NVj4dW5JRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H1770	NXLRWINtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXjJR\|UxRTJ6LkO1OlYhKM7:TR?=	M33OOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
BT-20	NGjnVIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NILNW\|BKSzVyPUK4MlM3QDViIN88US=>	NV60bWZCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
DBTRG-05MG	NH7Bc3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Ml3TTWM2OD1{OD60PFM5KCEQvF2=	M1HPWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HPAF-II	NV7ucJFxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWjwRY9oUUN3ME2yPE44PzliIN88US=>	NH;NWGE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SW837	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGLn[ZdKSzVyPUK5MlM{QDViIN88US=>	NIL6dXU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
647-V	M1vncGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFn6WpdKSzVyPUK5MlcxODNiIN88US=>	MoDDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
J82	NU\BeHNGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3r4VmlEPTB;MkmuPFAyOyBizszN	M2XTVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MC116	M{jtS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MoqyTWM2OD1\|MD6wO\|M{KCEQvF2=	Ml3DQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H69	Ml[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXSydVQ4UUN3ME2zNE43ODl\|IDFOwG0>	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NB6	NU\sWIVXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVrBXGJrUUN3ME2zNU4{PjJ7IDFOwG0>	M3PPV\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CAL-120	NYDRO2JIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUTJR\|UxRTN{LkSzNVchKM7:TR?=	NUTEcm04RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
U-87-MG	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2PyPGlEPTB;M{OuNFI2OSBizszN	NGf0O2g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1304	NHjQcYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{jVSmlEPTB;M{OuNFM2PCBizszN	NVHxWXN6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
YH-13	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NV;1THFFUUN3ME2zN{4zPTN3IDFOwG0>	NGnGbXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
RMG-I	MlS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEO1VYhKSzVyPUOzMlQzQDViIN88US=>	NXfVfYFtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LU-65	NYf4VnFnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVzmU4hFUUN3ME2zOE4yPDB6IDFOwG0>	NHPvWo09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
GB-1	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4T3dGlEPTB;M{WuNFczQSBizszN	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
DU-4475	NI\o[pFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUnWNphqUUN3ME2zOU4yPTV\|IDFOwG0>	NH7UcWQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SBC-5	NX\CbY57T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NEPNOpBKSzVyPUO2MlU6ODJiIN88US=>	M3HsflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
OE33	NGKxOpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVjJR\|UxRTN5Lke1O\|chKM7:TR?=	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
C8166	NFjzZmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MofBTWM2OD1\|OD61NlY4KCEQvF2=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
COLO-684	NHe2VJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIHuOIdKSzVyPUO4Mlc1OjhiIN88US=>	NGLPRWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1155	NGH5ZoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NEDyO5JKSzVyPUO5MlA1PzFiIN88US=>	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ATN-1	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MWfJR\|UxRTN7Lke3PVIhKM7:TR?=	M4j6ZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KARPAS-299	NXm2[2hNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVrJR\|UxRTN7LkizPUAh\|ryP	MlTKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KNS-81-FD	NH3OfFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NE\ifGVKSzVyPUSwMlM3ODRiIN88US=>	MojUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1563	MnH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NGrGOoZKSzVyPUSxMlUxOzliIN88US=>	NUTDemtHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NB14	M3LTNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1nr[mlEPTB;NEKuO\|I3OyBizszN	NVHDd3d[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
COLO-800	NXHrRVdjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MknxTWM2OD12Mj64OVE4KCEQvF2=	Mn\SQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MS-1	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NG\VZ4xKSzVyPUSzMlA1QDNiIN88US=>	MmfVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
OVCAR-8	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnuyTWM2OD12Mz62PFA6KCEQvF2=	M2HqclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SK-PN-DW	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mlj2TWM2OD12Mz64O\|c3KCEQvF2=	M1fKOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
G-402	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NHXlNY5KSzVyPUSzMlkxODZiIN88US=>	NE\4VHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H2291	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV7JR\|UxRTR2LkiwNVchKM7:TR?=	M4DVRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
PC-3	NWfTWJhsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYnJR\|UxRTR3LkiwNlMhKM7:TR?=	MonsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1581	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NH;nRYFKSzVyPUS1Mlk5QDliIN88US=>	NYXwdXIxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SW1116	MmX3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NH;kendKSzVyPUS3MlAyQDJiIN88US=>	M4XtPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ZR-75-30	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXfJR\|UxRTR5LkCyN\|khKM7:TR?=	NHLPO5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
OCI-AML2	NWf0NYVFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYj1PGlUUUN3ME20O{4xQTF6IDFOwG0>	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MDA-MB-231	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MU\JR\|UxRTR5Lk[yOFkhKM7:TR?=	MkPlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ES3	NEDidnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXnJbGRHUUN3ME20PE4{PTJ7IDFOwG0>	NV3jdo14RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H630	Mmm2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NICwd\|JKSzVyPUS5MlE4PDJiIN88US=>	NXOwdWNjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
OE19	MmTES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWPYbndQUUN3ME20PU4zQTB{IDFOwG0>	NIfrWZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1573	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1zwNmlEPTB;NEmuOlg3OSBizszN	NGi4NWU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
EW-1	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYTDZot{UUN3ME20PU46ODh2IDFOwG0>	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
K562	NXLQSXZQS3m2b4TvfIlkcXS7IHHzd4F6	NX;BW4NEPzJiaILz	MmPlR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT\|U3OiClZXzsd{Bie3Onc4Pl[EBieyClZXzsJJZq[WKrbHn0fUBi\nSncjC3NkBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gNE4xODR\|IN88UU4>	NXviW\|h5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[4NVQ5QTBpPkK2PFE1QDlyPD;hQi=>
HEK293	NX22fXVrTnWwY4Tpc44h[XO\|YYm=	MnnZNUBpeg>?	MYjJcohq[mm2aX;uJI9nKGi3bXHuJIZ2dGxibHXu[5RpKFCNTWnUNUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJJV{cW6pIFXGV{ApOjR5IITvJFI2QSC{ZYPp[JVmeyliYYOgd5Vje3S{YYTlJIFnfGW{IEGgbJIh[nliZnz1c5Jme2OnbnPlJJBwdGG{aYrheIlwdiCrbX31co9ie2G7LDDLbUA:KDBwMEGyO{DPxE1w	MoPyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEGxPVMoRjJ7OUSxNVk{RC:jPh?=
fibroblast cells	NYDmc2Q6SW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MofuRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDTdoMufHKjboPmc5Ju\WRicnH0NkBncWK{b3LsZZN1KGOnbHzzMEBKSzVyIE2gNE4yKM7:TT6=	NESzW4o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{G4NVE4OCd-MUexPFEyPzB:L3G+
fibroblast cells	MXTGeY5kfGmxbjDhd5NigQ>?		MXTJcohq[mm2aX;uJI9nKGi3bXHuJINUemNvdmPyZ{BnfXOrb36gdJJwfGWrbjDlfJBz\XO\|ZXSgbY4hemG2IH\pZpJw[myjc4SgZ4VtdHNiYomgSWxKW0FuIFnDOVAhRSByLkGg{txONg>?	MmDaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd7MEW1PFYoRjF5OUC1OVg3RC:jPh?=
Ba/F3	MXXGeY5kfGmxbjDhd5NigQ>?	M2nFTFQ5KGi{cx?=	MUXJcohq[mm2aX;uJI9nKEKFUj3BRmwyKEV\|NUXHJI12fGGwdDCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBud3W\|ZTDCZU9HOyClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJGJEWi2DQlyxMY1m\GmjdHXkJINmdGxicILvcIln\XKjdHnvckBi\nSncjC0PEBpenNiYomgRpJqfGWOaXfoeEBtfWOrZnXyZZNmKGG\|c3H5MEBIUTVyIE2gNE4yOjhizszNMi=>	NEnQfJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
HEK293	M1joOGZ2dmO2aX;uJIF{e2G7	NU\3O2RsOSCqch?=	M3vkVGlvcGmkaYTpc44hd2ZiaIXtZY4h\nWubDDs[Y5ofGhiUFvNXXQyKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMhfXOrbnegSWZUKCh{NEegeI8hOjV7IILld4llfWW\|KTDhd{B{fWK\|dILheIUh[W[2ZYKgNUBpeiCkeTDmcJVwemW\|Y3XuZ4UheG:uYYLpfoF1cW:wIHntcZVvd2G\|YYmsJGlEPTBiPTCwMlE{OyEQvF2u	MkXpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEGxPVMoRjJ7OUSxNVk{RC:jPh?=
Ba/F3	MW\GeY5kfGmxbjDhd5NigQ>?	NV30OHR3PDhiaILz	M4DqZWlvcGmkaYTpc44hd2ZiQlPSMWFDVDFiRUS1PWshdXW2YX70JEh2dmuwb4fuJI9zcWerbjmg[ZhxemW\|c3XkJIlvKG2xdYPlJGJiN0Z\|IHPlcIx{KGG\|c3Xzd4VlKGG\|IHnubIljcXSrb36gc4YhSkOULVHCUFEudWWmaXH0[YQh[2WubDDwdo9tcW[ncnH0bY9vKGGodHXyJFQ5KGi{czDifUBDemm2ZVzp[4h1KGy3Y3nm[ZJie2ViYYPzZZktKEeLNUCgQUAxNjF2IN88UU4>	NUKyNppNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CxN\|c6QDFpPkOwNVM4QThzPD;hQi=>
Ba/F3	NV\HXZhLTnWwY4Tpc44h[XO\|YYm=	NWHNb5FpPDhiaILz	NEHlcFVKdmirYnn0bY9vKG:oIFLDVk1CSkxzIFeyOVBJKG23dHHueEApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCvb4Xz[UBD[S:IMzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEKFUj3BRmwyNW2nZHnheIVlKGOnbHygdJJwdGmoZYLheIlwdiCjZoTldkA1QCCqcoOgZpkhSnKrdHXMbYdpfCCudXPp[oVz[XOnIHHzd4F6NCCJSUWwJF0hOC5zNE[g{txONg>?	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF\|N{m4NUc,OzBzM{e5PFE9N2F-
Ba/F3	M3zYW2Z2dmO2aX;uJIF{e2G7		NH7SR3BKdmirYnn0bY9vKG:oIF7QUU9CVEtiTEK1OnQhdXW2YX70JItqdmG\|ZTDhZ5Rqfmm2eTDpckBD[UZ\|IHPlcIx{KGK7IILh[Ilw\W68eX3heIlkKGG\|c3H5MEBKSzVyIE2gNE4yPSEQvF2u	NHv4U289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNkm3NFQxOCd-MU[5O\|A1ODB:L3G+
Ba/F3	M4LiOGZ2dmO2aX;uJIF{e2G7	MnnDOFghcHK\|	MojuTY5pcWKrdHnvckBw\iCEQ2KtRWJNOSC\MkWzTEBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBDS1JvQVLMNU1u\WSrYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOTd5IN88UU4>	MnrQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzM{e5PFEoRjNyMUO3PVgyRC:jPh?=
Ba/F3	NXzmSnNDTnWwY4Tpc44h[XO\|YYm=	NG\MVWM1QCCqcoO=	M4Tyb2lvcGmkaYTpc44hd2ZiQlPSMWFDVDFiRkO1PXYhdXW2YX70JEh2dmuwb4fuJI9zcWerbjmg[ZhxemW\|c3XkJIlvKG2xdYPlJGJiN0Z\|IHPlcIx{KGG\|c3Xzd4VlKGG\|IHnubIljcXSrb36gc4YhSkOULVHCUFEudWWmaXH0[YQh[2WubDDwdo9tcW[ncnH0bY9vKGGodHXyJFQ5KGi{czDifUBDemm2ZVzp[4h1KGy3Y3nm[ZJie2ViYYPzZZktKEeLNUCgQUAxNjF7NTFOwG0v	NEjuWnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
Ba/F3	Ml:1RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		M33kb2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcZVzcW6nIFLhSlMh[2WubIOg[ZhxemW\|c3nu[{BPWE1xQVzLJGwzPT[WIH31eIFvfCCkeTDbN2hefGi7bXnkbY5mKHWydHHr[UBie3OjeTygTWM2OCB;IECuNkDPxE1w	NXX0WpRlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[5O\|A1ODBpPkG2PVcxPDByPD;hQi=>
Ba/F3	MUPGeY5kfGmxbjDhd5NigQ>?		NF65R3VKdmirYnn0bY9vKG:oIF7QUU9CVEtiTEK1OnQhdXW2YX70JIF2fG:yaH;zdIhwenmuYYTpc44h[WO2aY\peJkhcW5iQnHGN{Bk\WyuczDifUBidnSrcHjvd5Bpd3S7cn;zbY5mKGmvbYXuc4Jtd3S2aX7nJIF{e2G7LDDJR\|UxKD1iMD6yJO69VS5?	MoTBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ7N{C0NFAoRjF4OUewOFAxRC:jPh?=
Ba/F3	MnLzSpVv[3Srb36gZZN{[Xl?	M1LrV\|Q5KGi{cx?=	MlLnTY5pcWKrdHnvckBw\iC5aXzkJJR6eGViQlPSMWFDVDFiKIXub45wf25ib4Lp[4lvMSCneIDy[ZN{\WRiaX6gcY92e2ViQnGvSlMh[2WubIOgZZN{\XO\|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKHC{b3zp[oVz[XSrb36gZYZ1\XJiNEigbJJ{KGK7IFLybZRmVGmpaISgcJVkcW[ncnHz[UBie3OjeTygS2k2OCB;IECuNlA1KM7:TT6=	NX\r[5FpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CxN\|c6QDFpPkOwNVM4QThzPD;hQi=>
Ba/F3	MkXISpVv[3Srb36gZZN{[Xl?	MXO0PEBpenN?	MoXaTY5pcWKrdHnvckBw\iCEQ2KtRWJNOSCTMkWyTEBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBDS1JvQVLMNU1u\WSrYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOjR\|IN88UU4>	MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF\|N{m4NUc,OzBzM{e5PFE9N2F-
Ba/F3	MUfGeY5kfGmxbjDhd5NigQ>?	M4jxVlQ5KGi{cx?=	MlzMTY5pcWKrdHnvckBw\iCEQ2KtRWJNOSCHMkW1WkBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBDS1JvQVLMNU1u\WSrYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOjd6IN88UU4>	NHr3OXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
Ba/F3	M1vuOmZ2dmO2aX;uJIF{e2G7	MW[0PEBpenN?	MXzJcohq[mm2aX;uJI9nKEKFUj3BRmwyKEV{NUXLJI12fGGwdDCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBud3W\|ZTDCZU9HOyClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJGJEWi2DQlyxMY1m\GmjdHXkJINmdGxicILvcIln\XKjdHnvckBi\nSncjC0PEBpenNiYomgRpJqfGWOaXfoeEBtfWOrZnXyZZNmKGG\|c3H5MEBIUTVyIE2gNE4{PTZizszNMi=>	MkjrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzM{e5PFEoRjNyMUO3PVgyRC:jPh?=
fibroblast cells	M3qzcWZ2dmO2aX;uJIF{e2G7		NEf1b3JKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gZYdicW6\|dDDBZowhfHKjboPmc5Ju\WRicnH0JIZq[nKxYnzhd5Qh[2WubIOsJGlEPTBiPTCwMlQ6KM7:TT6=	MmXJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZzNkG5PVUoRjF4MU[xPVk2RC:jPh?=
Ba/F3	MVLGeY5kfGmxbjDhd5NigQ>?	MVK0PEBpenN?	MVzJcohq[mm2aX;uJI9nKEKFUj3BRmwyKFR\|MUXJJI12fGGwdDCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBud3W\|ZTDCZU9HOyClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJINmdGxicILvcIln\XKjdHnvckBi\nSncjC0PEBpenNiYomgRpJqfGWOaXfoeEBtfWOrZnXyZZNmKGG\|c3H5MEBIUTVyIE2gNE43PDJizszNMi=>	M3rjOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMUO3PVgyLz5\|MEGzO\|k5OTxxYU6=
Ba/F3	MnvvRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		NXvhbmtOSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBufXKrbnWgRoFHOyClZXzsd{BmgHC{ZYPzbY5oKHerbHSgeJlx\SCQUF2vRWxMKGK7IGuzTH11cHmvaXTpcoUhfXC2YXvlJIF{e2G7LDDJR\|UxKD1iMTFOwG0v	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjl5MESwNEc,OTZ7N{C0NFA9N2F-
HepG2	MX;BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?	NV2ySIZqPDhiaILz	NYjEd45HSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDI[ZBIOiClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NEA:KDFwMUWg{txONg>?	NInsUnc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES4OVcyPSd-MUi0PFU4OTV:L3G+
HT29	NFvzRWRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	MVK0PEBpenN?	M17kWGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSGSyPUBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3MDC9JFEvOTdizszNMi=>	NHfYdXo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES4OVcyPSd-MUi0PFU4OTV:L3G+
BA/F3	NF;tSIJEgXSxdH;4bYNqfHliYYPzZZk>	M37mZVczKGi{cx?=	NUjxUZNlS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDCR3IuSUKOIGSzNVVKKG23dHHueEBi\nSncjC3NkBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gN{4zKM7:TT6=	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjhzNEi5NEc,OjZ6MUS4PVA9N2F-
HeLa	NHPMXFdHfW6ldHnvckBie3OjeR?=	MVi0MlUhcHK\|	NFXj[YRKdmirYnn0bY9vKG:oIFXic4xifmm{dYOg[4x6[2:ycn;0[YlvN22jdILpfEBxem:2ZXnuJHZRPDBiZX70dpkhcW5iaIXtZY4hUGWOYTDj[YxteyCjZoTldkA1NjViaILzJIJmfGFvbHHjeIFu[XOnIILldI9zfGW{IHHzd4F6NCCLQ{WwJF0hOy56NTFOwG0v	NGG4bYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OU[yOFM5Pyd-Mkm2NlQ{QDd:L3G+
HT29	NXXBc2NpSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=	NYTNZmZ1PDhiaILz	MVPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiWMkmgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO\|YYmsJGlEPTBiPTCzMlg4KM7:TT6=	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR6NUexOUc,OTh2OEW3NVU9N2F-
HepG2	NGPOVolCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	MW[0PEBpenN?	NE\qc2NCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjldGczKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCLQ{WwJF0hOy57MTFOwG0v	NVvMTGl3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0PFU4OTVpPkG4OFg2PzF3PD;hQi=>
HT29	MVXBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?	NFewRno1QCCqcoO=	NYDSXG1PSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWFI6KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCWR1mgQUA3NjVizszNMi=>	NGi4fmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES4OVcyPSd-MUi0PFU4OTV:L3G+
HepG2	NE[1bGdCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	NWeyXnR4PDhiaILz	MUDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEincFeyJINmdGy\|IHHmeIVzKDR6IHjyd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKGG\|c3H5MEBVT0liPTC3MlY3KM7:TT6=	MmTUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh2OEW3NVUoRjF6NEi1O\|E2RC:jPh?=
Ba/F3	NELy[3BE\WyuIHTlZZRpKGG\|c3H5		M2iwNWlv\HWldHnvckBw\iClZXzsJIRm[XSqIH;mJI12emmwZTDCZWY{KGOnbHzzJIV5eHKnc4PpcochVlCPL1HMT{BNOjV4VDDteZRidnRiYomgeJJ6eGGwIHLseYUh\XilbIXzbY9vKGG\|c3H5	Mo\LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ7N{C0NFAoRjF4OUewOFAxRC:jPh?=
A673	M2HPUpFJXFNiYYPzZZk>		Ml2xdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN?	M4fOS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
DAOY	NU\qS2ZneUiWUzDhd5NigQ>?		MWHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhTEGRWTDj[Yxtew>?	NHL3O3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
Saos-2	MXzxTHRUKGG\|c3H5		M1jSdZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVYX;zMVIh[2WubIO=	M2XvRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD	M1rNVpFJXFNiYYPzZZk>		M4X0R5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCURDDj[Yxtew>?	MmrKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
OHS-50	NFK2SopyUFSVIHHzd4F6		MX7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy\|	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
SK-N-MC	MY\xTHRUKGG\|c3H5		NELMdYpyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1OSyClZXzsdy=>	NGTlPVg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	p-Src / Src / p-c-Abl / c-Abl / p-S6 / S6 / p-ERK / ERK / p-STAT3 / STAT3; PubMed: 27903968 Oncotarget IMR-32, NB-19, SH-SY5Y, and SK-N-AS cells were treated with indicated concentrations of bosutinib for 0-8 hrs and the cells were lysed and subjected to immunoblotting with the indicated antibodies. β-Actin was used as a loading control in all experiments. p-FAK / FAK / p-Pyk2 / p-p130Cas / p-AKT; PubMed: 18483306 Mol Cancer Ther Western blot analysis of MDA-MB-468 whole cell extracts. Cells were treated with SKI-606 or 0.01% DMSO at the indicated concentrations for times up to 3 h prior to extraction. Immunoblots were probed as indicated with antibodies to phospho-Src (pY419), phospho-FAK (pYpY576/577 or pY925), phospho-Pyk2 (pY580), phospho-p130Cas (pY410), phospho-Stat3 (pY705), phospho-Akt (pS473), phospho-MAPK p44/42, beta-catenin, or PARP. Blots were re-probed with total anti-Src, anti-FAK, or anti-Stat3 antibodies, as indicated. p-ABL / ABL ; PubMed: 28199182 eLife Cells were transfected with human wild-type ABL, and p190 and p210 variants of BCR-ABL, treated with inhibitors for 24 hr and analyzed for activating phosphorylation (p) by immunoblot. Actin and total levels of expressed kinases serve as loading controls. Cells transfected with empty plasmid serve as transfection control.	27903968 18483306 28199182
Immunofluorescence	p-FAK / p-STAT3 / beta-catenin; PubMed: 18483306 Mol Cancer Ther MDA-MB-231 cells were treated with 0.01% DMSO or 1 µM SKI-606 for 48 h then fixed, probed with antibodies to phospho-FAK (pY576/pY577), FAK, phospho-Stat3 (pY705) or beta-catenin as indicated, and stained with DAPI. Images were captured under fluorescence at 40x magnification.	18483306
Growth inhibition assay	Cell viability; PubMed: 24812339 Bioinformatics Proliferation curves for bosutinib, gefitinib and sorafenib in (A) H1650 and (B) H1975. IC50; PubMed: 27903968 Oncotarget Six NB cell lines, IMR-32, NGP, NB-19, CHLA-255, SH-SY5Y, and SK-N-AS, were treated with increasing concentrations of bosutinib for 48 hrs. Cell viability was measured by performing the Cell Counting Kit-8 (CCK-8) assay.	24812339 27903968

In vivo

Bosutinib (60 mg/kg/day) is active against Src-transformed fibroblasts xenografts and HT29 xenografts in nude mice with T/C of 18% and 30%, respectively. ^[1] Oral administration of Bosutinib for 5 days significantly suppresses K562 tumor growth in mice in a dose-dependent manner, with the large tumors eradicated at dose of 100 mg/kg and tumor free at 150 mg/kg without overt toxicity. ^[2] As being inactive against Colo205 xenografts in nude mice at 50 mg/kg twice daily, Bosutinib dosing at 75 mg/kg twice daily is necessary against Colo205 xenografts, and increasing the dose of Bosutinib has no additional benefit, in contrast to the significant dose-dependent ability against HT29 xenografts. ^[4]

Protocol

Kinase Assay: ^[1]	- Collapse The Src and Abl kinase assays: The Src kinase activity is measured in an ELISA format. Src (3 units/reaction), reaction buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl₂, 0.1 mM EGTA, 0.5 mM Na₃VO₄) and cdc2 substrate peptide are added to various concentration of Bosutinib and incubated at 30 °C for 10 minutes. The reaction is started by the addition of ATP to a final concentration of 100 μM, incubated at 30 °C for 1 hour and stopped by addition of EDTA. Instructions from the manufacturer are followed for subsequent steps. The Abl kinase assay is performed in a DELFIA solid phase europium-based detection assay format. Biotinylated peptide (2 μM) is bound to streptavidin-coated microtitration plates for 1.5 hours in 1 mg/mL ovalbumin in PBS. The plates are washed for 1 hour with PBS/0.1% Tween 80, followed by a PBS wash. The kinase reaction is incubated for 1 hour at 30°C. Abl kinase (10 units) is mixed with 50 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, 80 μM EGTA, 100 μM ATP, 0.5 mM Na₃VO₄, 1% DMSO, 1 mM HEPES (pH 7.0), 200 μg/mL ovalbumin and various concentration of Bosutinib. The reaction is stopped with EDTA at a final concentration of 50 mM. The reaction is monitored with Eu-labeled phosphotyrosine antibody and DELFIA enhancement solution.
Cell Research: ^[2]	- Collapse Cell lines: Abl-MLV, Rat 2, KU812, K562, and MEG-01 cells Concentrations: Dissolved in DMSO, final concentrations ~1 μM Incubation Time: 72 hours Method: Cells are exposed to various concentrations of Bosutinib for 72 hours. Anchorage-independent proliferation of Abl-MLV-transformed fibroblasts is measured in 96-well ultra-low binding plates treated with Sigmacote to block residual cell attachment. Cell proliferation is measured with MTS or Cell-Glo. For the determination of cell cycle or cell death, cells are prepared for FACS analysis in the CycleTest Plus DNA reagent kit and analyzed on a fluorescence-activated cell sorter flow cytometer. (Only for Reference)
Animal Research: ^[2]	- Collapse Animal Models: Nude female mice injected with K562 cells Dosages: ~150 mg/kg/day Administration: Oral gavage (Only for Reference)

References

- Collapse

Solubility (25°C)

In vitro	DMSO	100 mg/mL (188.51 mM)
	Ethanol	2 mg/mL (3.77 mM)
	Water	Insoluble
In vivo	Add solvents to the product individually and in order(Data is from Selleck tests instead of citations): 2% DMSO+30% PEG 300+5% Tween 80+ddH2O For best results, use promptly after mixing.	10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download Bosutinib (SKI-606) SDF

Molecular Weight	530.45
Formula	C₂₆H₂₉Cl₂N₅O₃
CAS No.	380843-75-4
Storage	3 years-20°C powder 2 years-80°C in solvent
Synonyms	N/A
Smiles	CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step 2: Enter the in vivo formulation (Different batches have different solubility ratios, please contact Selleck to provide you with the correct ratio)

% DMSO+ % + % Tween 80+ % ddH₂O

Calculate Reset

Calculation results:

Working concentration： mg/ml；

Method for preparing DMSO master liquid: ： mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL， Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation：Take μL DMSO master liquid, next addμL PEG300， mix and clarify, next addμL Tween 80，mix and clarify, next add μL ddH₂O，mix and clarify.

Note：1.Please make sure the liquid is clear before adding the next solvent.
2.Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2021-01-06)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04258943	Recruiting	Drug: Bosutinib	Philadelphia Chromosome Positive CML\|Accelerated Phase Chronic Myelogenous Leukemia\|Blastic Phase Chronic Myelogenous Leukemia\|Chronic Phase Chronic Myelogenous Leukemia	Children''s Oncology Group\|Erasmus MC\|Dutch Childhood Oncology Group- Early Clinical Trial Consortium\|Innovative Therapies for Children with Cancer\|Pfizer	April 6 2020	Phase 1\|Phase 2
NCT03023319	Recruiting	Drug: Bosutinib\|Drug: Pemetrexed	Carcinoma Non-Small-Cell Lung\|Mesothelioma\|Bladder Cancer\|Ovarian Cancer\|Peritoneal Cancer\|Thymoma\|Thymus Cancer\|Uterine Cervical Cancer	Nagla Abdel Karim\|Augusta University	December 10 2019	Phase 1
NCT03888222	Recruiting	Drug: Placebo Oral Tablet\|Drug: Bosutinib Oral Tablet	Dementia With Lewy Bodies	Georgetown University\|Alzheimer''s Association	April 23 2019	Phase 2
NCT03854903	Recruiting	Drug: Palbociclib\|Drug: Bosutinib\|Drug: Fulvestrant	Metastatic Breast Cancer\|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast\|Hormone Receptor Positive Breast Cancer	Georgetown University\|Pfizer	April 1 2019	Phase 1
NCT03831776	Recruiting	Drug: Bosutinib\|Drug: Ropeginterferon	Chronic Myeloid Leukemia	St. Olavs Hospital\|Haukeland University Hospital\|Oslo University Hospital\|University Hospital of North Norway\|Helse Stavanger HF\|Henri Mondor University Hospital\|Hôpital René Huguenin\|Hôpital Mignot Versailles Paris\|Uppsala University Hospital\|Odense University Hospital	March 25 2019	Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
Can I give S1014 Bosutinib to mice by oral gavage? If so, how to dissolve the drug?
Answer:
For oral gavage, S1014 Bosutinib can be dissolved in 5% Tween 80+0.5% CMC Na at 30 mg/ml as a suspension.

Src Signaling Pathway Map

Src Inhibitors with Unique Features

Most Potent Src Inhibitor

Dasatinib : Src, IC50=0.8 nM.
FDA-approved Src Inhibitor

Dasatinib : Approved by FDA for CML and Ph+ ALL.
Newest Src Inhibitor

PP1 : Potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
Classic Src Inhibitor

KX2-391 : The first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

Related Src Products

Dasatinib Monohydrate ^New

Dasatinib Monohydrate (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively.
SU6656 ^New

SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
PX-478 2HCl ^New

PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. PX-478 2HCl induces apoptosis and has anti-tumor activity. Phase 1.
Saracatinib (AZD0530)

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM in cell-free assays, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q). Saracatinib induces autophagy. Phase 2/3.

Features:The 1st Src inhibitor to show inhibition of the Src pathway in human tumor tissue.
Dasatinib

Dasatinib (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM in cell-free assays, respectively. Dasatinib induces autophagy and apoptosis with anti-tumor activity.
KX2-391 (Tirbanibulin)

KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
PP1

PP1 (AGL 1872, EI 275) is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
PP2

PP2 (AG 1879, AGL 1879), a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM in cell-free assays, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA.
WH-4-023

WH-4-023 (KIN001-112, KIN112, Dual LCK/SRC inhibitor) is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.
Ibrutinib (PCI-32765)

Ibrutinib (PCI-32765) is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM in cell-free assays, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc. Ibrutinib is applicable as a Btk ligand in the synthesis of a series of PROTACs including P13I.

Choose Your Country or Region

By Signaling Pathways

By product type

Bosutinib (SKI-606)